BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26437266)

  • 1. Changes in liver acceptance patterns after implementation of Share 35.
    Washburn K; Harper A; Baker T; Edwards E
    Liver Transpl; 2016 Feb; 22(2):171-7. PubMed ID: 26437266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Share 35 changes in center-level liver acceptance practices.
    Goldberg DS; Levine M; Karp S; Gilroy R; Abt PL
    Liver Transpl; 2017 May; 23(5):604-613. PubMed ID: 28240804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait-list mortality.
    Mitchell E; Loomes KM; Squires RH; Goldberg D
    Liver Transpl; 2018 Jun; 24(6):803-809. PubMed ID: 29506323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Offer Acceptance Patterns for Liver Donors Aged 70 and Older.
    Haugen CE; Bowring MG; Jackson KR; Garonzik-Wang J; Massie AB; Chiang TP; Philosophe B; Segev DL; Halazun KJ
    Liver Transpl; 2022 Apr; 28(4):571-580. PubMed ID: 34559954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality.
    Nicolas CT; Nyberg SL; Heimbach JK; Watt K; Chen HS; Hathcock MA; Kremers WK
    Liver Transpl; 2017 Jan; 23(1):11-18. PubMed ID: 27658200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for End-Stage Liver Disease-Sodium Score: The Evolution in the Prioritization of Liver Transplantation.
    Machicao VI
    Clin Liver Dis; 2017 May; 21(2):275-287. PubMed ID: 28364813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Share 35 Policy on Liver Transplantation Outcomes for Patients With Nonalcoholic Steatohepatitis.
    Zhang Y; Boktour MR
    Prog Transplant; 2019 Sep; 29(3):248-253. PubMed ID: 31146627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant.
    Wey A; Pyke J; Schladt DP; Gentry SE; Weaver T; Salkowski N; Kasiske BL; Israni AK; Snyder JJ
    Liver Transpl; 2018 Apr; 24(4):478-487. PubMed ID: 29316203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same policy, different impact: Center-level effects of share 35 liver allocation.
    Murken DR; Peng AW; Aufhauser DD; Abt PL; Goldberg DS; Levine MH
    Liver Transpl; 2017 Jun; 23(6):741-750. PubMed ID: 28407441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.